Article
Genetic and epigenetic factors determining NAFLD risk.
Molecular metabolism - 1 Aug 2021
Jonas Wenke, Schürmann Annette
Abstract excerpt
BACKGROUND: Hepatic steatosis is a common chronic liver disease that can progress into more severe stages of NAFLD or promote the development of life-threatening secondary diseases for some of those affected. These include the liver itself (nonalcoholic steatohepatitis or NASH; fibrosis and cirrhosis, and hepatocellular carcinoma) or other organs such as the vessels and the heart (cardiovascular disease) or the...
Topics
Join the communities discussing this publication.